Congratulations to
#neurosurgeryresident Sarah Sternbach, MD, and her collaborators in the Neurocritical Care Program at
#BarrowNeurologicalInstitute on receiving the Natus Resident/Fellow Award for Neurocritical Care at the American Association of Neurological Surgeons (AANS) Annual Meeting (
#AANS2026)!
@AANSNeuro presents this award to the best
#neurocriticalcare abstract submitted by a resident or fellow. Dr. Sternbach performed this research with pharmacy specialist Tyler Haller, PharmD, BCCCP, and acute care nurse practitioner Diane McLaughlin, DNP, AGACNP-BC, CCRN, FCCM, FNCS, MBA. She credits them with conceiving the project and welcoming her participation.
The team performed a retrospective cohort study of patients with acute
#braininjuries. These patients had dangerously high blood pressure despite receiving maximal doses of nicardipine and thus were switched from the first-line medication to another agent, known as clevidipine.
Drs. Sternbach, Haller, and McLaughlin found that nearly 85% of these patients achieved blood pressure control within one hour of starting clevidipine and that side effects were rare. Their study suggests that clevidipine is a safe and an effective rescue option for one of the most challenging problems in neurocritically ill patients.